Full Application deadline (by invite only): Mar. 31, 2016
Phase I – Letter of Intent (LOI) deadline: September 24, 2015
Phase II – Full Application deadline: March 31, 2016 (by invitation only)
Appropriateness – health services that are relevant to user needs and are based on evidence-based practice.
Currently Accepting Applications
Deadline: Jul. 31, 2015
Value & Term
Up to $10,000
Amount of funding is dependent on: audience size and reach; scope of activity; alignment to Alberta Innovates – Health Solutions’ (AIHS) mandate; funding from other sources; other competing requests received; and anticipated impact of proposed activity.
Applications will be accepted four times a year: April, July, October and January(based upon availability of funds). Applications must be submitted at least three months prior to the activity.
The promotion and awareness of science, research and innovation has many impacts within the public and academic communities. By helping the public to better understand science and health research, and by helping the research community to share this information, we build leaders of the future and a stronger health research and innovation environment.
The Community Engagement and Conference Grant is designed to cover a broad spectrum of activities, including those that promote collaboration and networking in the area of health research and innovation.
Activities should align with the mandate of Alberta Innovates – Health Solutions (AIHS) to promote the health, social and economic wellbeing of Albertans through research and innovation. Activities should also demonstrate the intent to promote collaboration and exchange between community groups, individuals, research groups, academic institutions, and organizations in Alberta and beyond.
Some examples of eligible health research and innovation activities include, but are not limited to, those that:
- encourage public understanding and engagement in Alberta’s health research and innovation enterprise;
- connect researchers, end-users and industry and showcase knowledge in a defined scientific discipline;
- bring key stakeholders, researchers and/or community groups together to discuss opportunities and challenges for improving health care in Alberta;
- connect trainees and promote scientific research in various disciplines;
- showcase leading edge clinical and research work being done in Alberta;
- encourage collaborations between researchers and community groups in Alberta and beyond;
- provide professional development opportunities for a defined set of individuals in academic or non-academic settings and encourage the exchange of information and networking among participants.
A broad range of activities may be considered for support from the Community Engagement and Conference Grant. Please contact us if you have questions regarding the eligibility of your proposed activity.
More information on the Community Engagement and Conference Grant, including the objectives, review process and allowable costs, can be found the in Program Guide.
For more information:
Nicole Tjepkema, Officer, Industry & Technology Initiatives
The ATI is pleased to announce two new grant competition partnerships with the Canadian National Transplant Research Program (CNTRP) to support new research ideas and training opportunities. This partnership provides an opportunity for ATI members to bring their research into this important national transplant research platform.
- provide recognition and support to students early in their academic research career, providing them with an opportunity to gain research experience
- support the training and development of future researchers in the field of organ and cell donation and transplantation in order to advance CNTRP’s objectives to increase organ and tissue donation in Canada and enhance the survival and quality of life of Canadians who receive transplants with the ultimate goal of improving patient care.
The ATI is providing an additional $25,000 CDN/year over a period of two years to support the top ranked application of an Alberta trainee who applies to the CNTRP Astellas Training Grant Competition. It is required that award recipients secure and demonstrate a commitment of matching funding to receive the award.
APPLICATION DEADLINE: July 15, 2015
Additional details regarding the eligibility criteria and application process can be found at www.cntrp.ca/training_award
Dr. Lori West and Dr. Marie-Josée Hébert were presented the 2015 Dr. John B. Dossetor Research Award from the Kidney Foundation of Canada during the Annual CNTRP Meeting in Montebello last week. This award is presented to an individual or group who merits special recognition for outstanding service or other contributions to The Kidney Foundation of Canada’s Research activities. (Read more)
The “Alberta Organ and Tissue Donation Registry” has been recognized for the second year in a row by the Project Management Institute-Northern Alberta Chapter (PMINAC). Congratulations to Sherri Kashuba (Managing Director) and Laura Grantham (Manager-Regulation, Policy, Directive & Communication) on the hard work and dedication to launching the online consent-to-donate Registry and for raising the profile of organ and tissue donation in Alberta. If you’d like to officially register your consent to donate in Alberta check out Alberta Health’s link at: https://myhealth.alberta.ca/Pages/OTDRHome.aspx?selected=overview
Enhancing Astellas’ sustained commitment to research and development within the transplant scientific community is the introduction of the 2015 CNTRP Astellas Training Award Competition. The intention of this collaborative effort between Astellas and the CNTRP is to encourage the training and development of future researchers in the field of cell and organ donation and transplantation to improve long-term health outcomes and quality of life for transplant patients. Astellas will provide the funding for the Training Awards. The CNTRP Training and Career Development Platform (Training) committee will set guidelines for the competition, receive and adjudicate the applications. The Canadian Liver Foundation, partner and supporter of the CNTRP, will provide financial administration for the Training Awards on behalf of the CNTRP and will disburse funds to the selected award recipient(s).
The CNTRP is now accepting applications for the CNTRP/Astellas Training Award Competition, due July 1, 2015. This collaborative effort between Astellas Pharma Canada and the CNTRP is intended to encourage the training and development of future researchers in the field of cell and organ donation and transplantation to improve long-term health outcomes and quality of life for transplant patients.
Two (2) grants with a maximum value of $50,000 CDN will be awarded over a period of two years. It is required that award recipients secure and demonstrate a commitment of matching funding to receive the award.
Application Deadline: August 18th, 2015
COMPETITION NOW OPEN
Astellas Pharma Canada is partnering with the CNTRP to provide $75,000 to support peer-reviewed pilot research projects that will contribute to the mandate of the CNTRP. The objective of the CNTRP Astellas Research Innovation Grant competition is to support peer-reviewed pilot research project(s) that align with CNTRP’s overall objective to increase organ and tissue donation in Canada and enhance the survival and quality of life of Canadians who receive transplants with the ultimate goal of improving patient care.
The primary area of focus for this competition is to nurture innovative research aligning with the strategic research priority of the CNTRP in the area of personalized medicine approaches in transplantation to improve health outcomes.
For More Information CLICK HERE
Dr. Rob Fairchild, Professor of Molecular Medicine at the Cleveland Clinic Lerner School of Medicine and Professor in the Department of Pathology at Case Western Reserve University School of Medicine, will be speaking at the ATI Seminar Series on Wednesday, June 17 from 12:00-1:00 pm. Dr. Fairchild is a highly accomplished transplant immunologist whose research is focused on mechanisms of allograft rejection and T cell-mediated inflammation. His current research projects include investigations of the impact of endogenous CD8 memory T cell activity on allograft outcome and of mechanisms underlying antibody mediated rejection of renal allografts using mouse models as well as clinical samples.